Nicola A Hanania Selected Research

Nebulizers and Vaporizers (Inhaler)

1/2023	COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA.
12/2022	Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus dual therapy in current and former smokers with COPD: IMPACT trial post hoc analysis.
1/2021	Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical Trials.
1/2021	Reducing the hidden burden of severe asthma: recognition and referrals from primary practice.
1/2021	Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
1/2021	Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.
1/2021	InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions.
1/2021	Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial.
1/2020	Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment.
10/2018	Confronting the Challenge of COPD: What Is New in the Approaches to Diagnosis, Treatment, and Patient Outcomes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicola A Hanania Research Topics

Disease

109	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 09/2003
101	Asthma (Bronchial Asthma) 02/2024 - 04/2004
35	Inflammation (Inflammations) 05/2024 - 03/2005
12	Dyspnea (Shortness of Breath) 01/2024 - 02/2007
8	Pneumonia (Pneumonitis) 12/2023 - 05/2013
6	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2023 - 03/2011
5	Infections 12/2023 - 01/2010
5	Emphysema 12/2017 - 06/2007
4	Airway Obstruction (Choking) 01/2024 - 10/2017
4	Hypersensitivity (Allergy) 01/2023 - 04/2008
4	COVID-19 11/2021 - 05/2020
4	Disease Progression 12/2019 - 01/2008
3	Human Influenza (Influenza) 12/2023 - 04/2004
3	Hypoxia (Hypoxemia) 10/2022 - 08/2011
3	Chronic Disease (Chronic Diseases) 10/2020 - 01/2011
2	Body Weight (Weight, Body) 01/2024 - 09/2014
2	Lung Injury 05/2021 - 01/2019
2	Lung Diseases (Lung Disease) 01/2019 - 01/2017
2	Neoplasms (Cancer) 01/2019 - 01/2018
2	Chronic Bronchitis 08/2016 - 01/2016
2	Eosinophilia 01/2016 - 01/2014
2	Respiratory Sounds (Crackle) 01/2011 - 12/2008
2	Respiratory Hypersensitivity 02/2009 - 01/2008
1	Hepatitis C 10/2023

Drug/Important Bio-Agent (IBA)

57	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 09/2003
37	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2011
33	Bronchodilator Agents (Bronchodilators)IBA 12/2023 - 09/2004
19	Formoterol Fumarate (Oxis)FDA Link 01/2021 - 01/2006
15	Interleukin-13IBA 05/2024 - 09/2011
15	Omalizumab (Xolair)FDA Link 01/2024 - 04/2008
14	Immunoglobulin E (IgE)IBA 01/2024 - 04/2008
14	GoldIBA 01/2024 - 03/2011
13	dupilumabIBA 05/2024 - 01/2018
13	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2023 - 04/2013
11	Monoclonal AntibodiesIBA 05/2024 - 04/2008
10	CytokinesIBA 12/2023 - 12/2009
9	Albuterol (Salbutamol)FDA LinkGeneric 01/2021 - 05/2005
9	PeriostinIBA 01/2020 - 04/2013
8	Interleukin-4 (Interleukin 4)IBA 05/2024 - 05/2014
8	SteroidsIBA 11/2023 - 04/2004
8	vilanterolIBA 01/2023 - 07/2012
7	lebrikizumabIBA 02/2024 - 09/2011
7	Tiotropium Bromide (Spiriva)FDA Link 11/2023 - 10/2007
7	Muscarinic AntagonistsIBA 11/2023 - 01/2015
7	Oxygen (Dioxygen)IBA 01/2023 - 12/2005
7	fluticasone furoate FDA Link 01/2023 - 05/2013
6	Salmeterol Xinafoate (Serevent)FDA Link 01/2013 - 09/2003
5	InterleukinsIBA 10/2023 - 12/2009
5	GSK573719IBA 01/2023 - 01/2021
5	Budesonide (Pulmicort)FDA LinkGeneric 01/2021 - 01/2006
5	AllergensIBA 11/2020 - 04/2008
5	Interleukin-5 (Interleukin 5)IBA 01/2019 - 05/2014
5	Cholinergic Antagonists (Anticholinergics)IBA 01/2015 - 10/2007
4	SolutionsIBA 01/2019 - 02/2008
3	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022 - 08/2018
3	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2021 - 01/2017
3	SuspensionsIBA 04/2020 - 11/2016
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2011
3	Fluticasone (Cutivate)FDA LinkGeneric 01/2020 - 09/2003
3	LeukotrienesIBA 01/2019 - 04/2008
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2017 - 01/2010
3	tartaric acid (tartrate)FDA Link 12/2014 - 02/2007
3	AntigensIBA 01/2012 - 04/2004
3	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 02/2010 - 05/2005
3	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2006 - 04/2004
2	tezepelumabIBA 12/2023 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2017
2	Hypnotics and Sedatives (Sedatives)IBA 01/2023 - 01/2019
2	benralizumabIBA 01/2023 - 01/2018
2	ProstaglandinsIBA 01/2022 - 01/2019
2	AerosolsIBA 01/2021 - 08/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2011
2	Vitamin D FDA LinkGeneric 04/2013 - 01/2011
2	SmokeIBA 03/2012 - 10/2010
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2012 - 05/2005
2	Phenobarbital (Luminal)FDA Link 10/2010 - 06/2007
2	Peptide Hydrolases (Proteases)FDA Link 01/2010 - 05/2008
2	Levalbuterol (Xopenex)FDA LinkGeneric 01/2008 - 05/2006
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 12/2005 - 03/2005
1	Thymic Stromal LymphopoietinIBA 12/2023
1	Antiviral Agents (Antivirals)IBA 12/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Chemokine CCL17IBA 10/2023
1	Chemokine CCL26IBA 10/2023

Therapy/Procedure

79	Therapeutics 12/2023 - 02/2002
16	Nebulizers and Vaporizers (Inhaler) 01/2023 - 09/2003
9	Metered Dose Inhalers (Metered Dose Inhaler) 01/2021 - 02/2007
8	Drug Therapy (Chemotherapy) 01/2023 - 12/2007
6	Biological Therapy 01/2021 - 01/2016
4	Precision Medicine 01/2018 - 08/2016
3	Artificial Respiration (Mechanical Ventilation) 10/2022 - 05/2012
3	Length of Stay 03/2022 - 05/2012
3	Dry Powder Inhalers 01/2020 - 01/2018
3	Patient Readmission 01/2020 - 05/2015
2	Secondary Prevention 01/2022 - 10/2007
2	Polypharmacy 11/2016 - 10/2010
2	Bronchial Thermoplasty 12/2013 - 07/2011
2	Pneumonectomy (Lung Volume Reduction) 01/2008 - 12/2005